Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12867359 | 1.00 | CA1 (0.33) | CA1CA2GABRR1DPP4EPHX1 | |
| SCHEMBL10164157 | 1.00 | CA1 (0.33) | CA1CA2GABRR1DPP4EPHX1 | |
| SCHEMBL14321927 | 0.82 | PIK3CD (0.34) | CA1CA2GABRR1 | |
| SCHEMBL25098364 | 0.80 | CA1 (0.31) | CA1CA2GABRR1 | |
| SCHEMBL20154129 | 0.80 | ALDH1A1 (0.34) | CA1CA2GABRR1 | |
| SCHEMBL15672770 | 0.78 | CA1 (0.34) | CA1CA2EPHX1 | |
| SCHEMBL8621952 | 0.78 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL11564015 | 0.78 | CA1 (0.31) | CA1 | |
| SCHEMBL1244953 | 0.77 | EPHX1 (0.34) | GABRR1EPHX1 | |
| SCHEMBL13180020 | 0.77 | EPHX1 (0.34) | GABRR1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024024951-A1 | BINDER COMPOSITION FOR SECONDARY BATTERY, ELECTRODE SHEET AND SECONDARY BATTERY, AND METHOD FOR PRODUCING ELECTRODE SHEET AND SECONDARY BATTERY | 富士フイルム株式会社 | 2024-02-01 | — | — | WO | disclosed |
| US-11717793-B2 | Functional fibrous membrane, method for manufacturing the same, filter comprising the same | KING'S FLAIR DEVELOPMENT LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
| WO-2023120533-A1 | BINDER COMPOSITION FOR SECONDARY BATTERIES, ELECTRODE SHEET, SECONDARY BATTERY, METHOD FOR PRODUCING ELECTRODE SHEET AND METHOD FOR PRODUCING SECONDARY BATTERY | 富士フイルム株式会社 | 2023-06-29 | — | — | WO | disclosed |
| EP-3207093-B1 | RESIN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | ECOLAB USA INC (US) | 2020-11-25 | — | — | EP | disclosed |
| EP-2997613-B1 | REDOX FLOW CELL FOR STORING ELECTRICAL ENERGY AND USE THEREOF | Jenabatteries GmbH (DE) | 2017-11-22 | — | — | EP | disclosed |
| US-9296698-B2 | Amino heteroaryl compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2016-03-29 | — | — | US | disclosed |
| US-20120329830-A1 | Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use | AMGEN INC. (US) | 2012-12-27 | — | — | US | disclosed |
| EP-2504315-A1 | AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | Amgen Inc. (US) | 2012-10-03 | — | — | EP | disclosed |
| EP-2492751-A1 | Lithographic printing plate precursor and plate making method thereof | Fujifilm Corporation (JP) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011063233-A1 | AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2011-05-26 | — | — | WO | disclosed |
| US-20070088142-A1 | PERFLUOROVINYL ETHER MONOMER HAVING A SULFONAMIDO GROUP | IKEDA MASANORI | 2007-04-19 | — | — | US | disclosed |
| US-20040122256-A1 | Perfluorvinyl ether monomer having sulfonamide group | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2004-06-24 | — | — | US | disclosed |
| CN-1500075-A | Perfluorovinyl ether monomer having sulfonamide group | 旭化成株式会社 | 2004-05-26 | — | — | CN | disclosed |
| EP-1359142-A1 | PERFLUOROVINYL ETHER MONOMER HAVING SULFONAMIDE GROUP | Asahi Kasei Kabushiki Kaisha (JP) | 2003-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122256-A1 | Perfluorvinyl ether monomer having sulfonamide group | AFF1, MFAP1, PFN1 | CA1 867/4885CA2 1743/4885GABRR1 1031/4885 |
| US-20120329830-A1 | Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use | BACE1, BACE2, APP | CA1 1047/4885CA2 4037/4885GABRR1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.